Anti-Human CCR2 Recombinant Antibody (Plozalizumab)

CAT#: TAB-444CQ

Recombinant monoclonal antibody to CCR2. Plozalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2.

Gene Expression
Figure 1 IF staining of human cell line THP-1 Figure 2 IHC staining of human cervix, uterine Figure 3 Cervix Figure 4 Lymph node Figure 5 RNA cell line category: Cell line enhanced (Karpas-707, THP-1, U-266/70, U-266/84)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • IgG1, κ
  • Specificity
  • Human CCR2
  • Species Reactivity
  • Human
  • Applications
  • Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
  • Conjugate
  • Unconjugated
  • CAS
  • 1610761-46-0
  • Generic Name
  • Plozalizumab
  • UNII
  • 4XG66BMN0D
  • Related Disease
  • Atherosclerosis, Diabetic nephropathies, Malignant melanoma

Product Property

  • Purity
  • > 95% as determined by SDS-PAGE
  • Storage
  • Store at -20°C for long-term storage. Avoid freeze/thaw cycles.

Target

  • Alternative Names
  • Chemokine (C-C Motif) Receptor 2; Monocyte Chemoattractant Protein 1 Receptor; CC-CKR-2; MCP-1-R; CMKBR2; CCR-2; Monocyte Chemotactic Protein 1 Receptor; MCP-1 Receptor; CD192 Antigen; C-C CKR-2; CCR2A; CCR2B; CD192; CKR2A; CKR2B; CKR2
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-444CQ. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Plozalizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Plozalizumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Plozalizumab"

Afuco™ Anti-CCR2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-444CQ)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CCR2. It is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2.
DrugMonitor™ Anti-Plozalizumab Antibody (VS-1224-YC931)
Plozalizumab has been researched for treating atherosclerosis as a humanized monoclonal antibody specifically targeting CCR2. The DrugMonitor™ Anti-Plozalizumab Antibody (VS-1224-YC931) is an anti-drug antibody (ADA) against Plozalizumab. This drug-based antibody is raised in mice immunized with the Plozalizumab. The anti-Plozalizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Plozalizumab in samples.

See other products for "CCR2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-099CL Anti-Human CCR2 Recombinant Antibody (MLN1202) FuncS Antibody
CAT Product Name Application Type
BRD-0096MZ Chicken Anti-CCR2 Polyclonal IgY WB Chicken antibody
BRD-0127MZ Chicken Anti-CKR2 Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
MOR-0520 Hi-Affi™ Rabbit Anti-CCR2 Recombinant Antibody (clone DS520AB) WB, FC, IP, IHC-Fr, IHC-P Rabbit IgG
CAT Product Name Application Type
AFC-TAB-444CQ Afuco™ Anti-CCR2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-444CQ) ELISA, IHC, FC, IP, IF, Inhib ADCC enhanced antibody
CAT Product Name Application Type
VS-0724-YC1087 AbPlus™ Anti-CCR2 Magnetic Beads (VS-0724-YC1087) IP, Protein Purification
CAT Product Name Application Type
VS-0225-XY11 CytoStream™ Mouse Anti-CCR2 Recombinant Antibody (VS-0225-XY11) FC Mouse IgG2b
CAT Product Name Application Type
VS-0425-FY74 Human Anti-CCR2 (clone MLN1202) scFv-Fc Chimera IA Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC148 Recombinant Anti-CCR2 Vesicular Antibody, EV Displayed (VS-0425-YC148) ELISA, FC, Inhib, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare